Non classé
DiCE participated in the successful in-person Patient Engagement Open Forum (#PEOF2022) in Barcelona!
DiCE participated in three exciting days of innovative and inspiring live workshops. The patient & people-centric sessions offered the chance t...
Looking into 2023, Pharma Legislation & Health Data Set to Dominate the Health Policy Space
DiCE welcomed the proposal for a regulation to set up European Health Data Space (EHDS). We believe that health data can improve health systems and...
DiCE is proud to be part of the #myUEGcommunity at UEGWeek2022
At DiCE, we strongly believe in cooperation and working together, which is why it was our pleasure to join UEG at their yearly congress in Vienna t...
Patients with Locally Advanced Mismatch Repair Deficient Colon Cancer can Benefit from Immunotherapy—the Promising Results of the NICHE-2 Clinical Trial
Encouraging results on the use of immunotherapy for patients with deficient mismatch repair colon cancer were presented at the ESMO Congress 2022 i...
Commission Unveiled New Proposed Cancer Screening Recommendations – Gastric Cancer Included for the First Time
Updated recommendation on cancer screening is based on the latest scientific advice. The new guidance updates the 2003 Council Recommendation and i...
DiCE Award Helps EuropaColon Polska Pregnancy Project Come to Life
EuropaColon Polska launches campaign for pregnant women on the risks and signs and symptoms of CRC with help from DiCE Award
...
New Normal, Same Cancer Campaign Continues
New Normal, same Cancer campaign continues – with specific materials on certian tumour types also now available
...
Welcome to A.R.CA.D – Our New French Member
Welcome to our new Member organisation A.R.CA.D from France – strengthening our collective voice in fighting digestive cancers for patients!<...
